CTLA4 and temporal arteritis: For instance, the trend toward lower CTLA‐4 levels in patients with PMR with concomitant GCA compared with those with PMR alone might reflect biologic differences in immune regulation, but larger studies are needed to establish clinically meaningful thresholds and confirm these findings.